Predicting MDS Response to Drug Therapies Based on a New Method of Interpreting the MDS Mutanome

Background: Unfortunately, 60% of MDS patients fail to achieve a response to HMAs and 33% of del(5q) patients fail to achieve transfusion independence after lenalidomide.